Neochlorogenic acid has been shown to improve lipid profiles, hepatic steatosis, and inflammation in db/db mice with glucotoxicity, possibly by downregulating miR-34a and activating the SIRT1/AMPK pathway (Tsai et al., 2024; Yu et al., 2021). Here, SIRT1 is linked to fatty liver disease.